Sign in
CompletedNo phase

A Study of Digital Cognitive Behavioural Therapy for Insomnia in Fibromyalgia

Key facts

Who runs it
University of Oxford
Where
United Kingdom1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
80 people enrolled
Started
1 Jun 2023
Ended
31 Dec 2025
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • Digital Cognitive Behavioural Therapy for Insomnia
Record updated
12 May 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 15 criteriaShow less

Who can take part

  • Clinical diagnosis of fibromyalgia
  • Concomitant insomnia, frequent waking in the night or early morning waking
  • Self-reported difficulties with concentration or memory
  • Reliable internet access

Who cannot take part

  • Recent or planned surgery
  • Taking prescribed sleep medications on more than 2 nights in past 2 weeks
  • Currently receiving other psychological therapy for insomnia
  • Patients with known neurological or psychiatric conditions (other than depression or anxiety) likely to independently affect the results of pain assessment, for example peripheral diabetic neuropathy in the opinion of the research team
  • Major neuropsychiatric disorder (bipolar disorder, schizophrenia or psychotic spectrum disorders)
  • Epilepsy
  • Cognitive impairment, dementia or neurodegenerative disorder
  • Sleep disorders such as sleep apnoea, restless leg syndrome, circadian rhythm disorder, or parasomnia
  • Patients with a poor understanding of English
  • Current or planned night-time shift work
  • Pregnant or lactating

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The goal of this clinical trial is to investigate the potential benefits of a digital Cognitive Behavioural Therapy for Insomnia (dCBT-I) platform, Sleepio, in individuals suffering from fibromyalgia, a condition commonly associated with cognitive issues and sleep disorders.

Read full original descriptionShow less

The main questions this study aims to answer are:

* Does the application of Sleepio improve quality of life in individuals with fibromyalgia? * Does the use of Sleepio improve cognitive function in individuals with fibromyalgia? * Does the use of Sleepio enhance sleep quality in these same individuals? * Does the use of Sleepio improve motor function in this group?

Participants will be randomly assigned to either use the Sleepio platform or standardised health advice, including sleep hygiene material. Those assigned to Sleepio will undergo a series of six 20-minute sessions over 10 weeks with a virtual therapist focusing on cognitive and behavioural strategies for improving sleep.

Participants' quality of life, cognitive function, sleep quality, and pain levels will be monitored and evaluated using online assessment tools. Additionally, a subset of participants will undergo further testing via sleep actigraphy and/or neuroimaging with MRI scans.

Researchers will compare the two groups to determine if the use of Sleepio has a positive effect on quality of life, cognitive function, and sleep quality.

The 2 groups in the trial

  • Sleepio (dCBT-I)Treatment being tested

    6-10 weeks of digital cognitive behavioural therapy for insomnia (Sleepio) delivered online. Participants will also receive a booklet with general advice for patients with fibromyalgia, including sleep hygiene.

    Treatment: Digital Cognitive Behavioural Therapy for Insomnia

  • Treatment as usualNo study treatment, for comparison

    Participants will receive a booklet published by Versus Arthritis designed for patients with fibromyalgia with general advice, including sleep hygiene.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Characterisation of Pain in Patients With Musculoskeletal Disease: a Prospective, Longitudinal, Observational Study With an Embedded Feasibility Window of Opportunity Sleep Study
Record updated
12 May 2026